[Top] [All Lists]

[e-drug] Independent Drug and Healthcare Newsletter for June 2018

E-DRUG: Independent Drug and Healthcare Newsletter for June 2018

Independent Drug & Healthcare Newsletter from the non-profit journal  Prescrire 

Newsletter, June 2018
> View the contents

If your friends or colleagues would be interested, forward this email and 
invite them to sign up for the free Newsletter.

Like what you see?
Subscribe to Prescrire International

In Prescrire's Spotlight this month
FEATURED REVIEW  Human papillomavirus 9-valent vaccine (Gardasil 9°) and 
cervical cancer. A few cases of dysplasia prevented, but an increase in painful 
A human papillomavirus (HPV) vaccine containing 9 HPV genotypes (Gardasil 9°) 
has been authorised in the European Union. The 9-valent vaccine provokes more, 
sometimes severe, injection site reactions, which could intensify existing 
misgivings about HPV vaccination.
> Read more

FREE DOWNLOAD  In the June issue of Prescrire International: anti-TNF alpha is 
linked to lymphoma; tropicamide eye drops present a risk of misuse
Download this free page from the Adverse Effects of the June issue, to get a 
sampling of the quality and diversity of the information published in every 
issue of Prescrire International.
> Read more

Antibiotics: repeated treatments before the age of two could be a factor in 
Antibiotics disrupt the intestinal flora (intestinal microbiota) and could be a 
factor in weight gain. Prescription of antibiotics for children should not be 
automatic but should be evaluated on a case-by-case basis.
> Read more

Independence, in the service of patients' best interests
Prescrire is 100% financed by its subscribers, which guarantees its freedom 
from the influence of any special interests - be they industrial or 
institutional. This is the precondition for reliable, unbiased information and 
continuing education for healthcare professionals.
> Read more

Prescrire's policy advocacy: advancing healthcare policy
ABOUT PRESCRIRE  Prescrire acts as a force for change in health policies, first 
and foremost in the interest of patients. Working together with other 
organisations, Prescrire's policy advocacy is a source of constructive 
proposals, counterbalancing the influence of purely commercial interests.
> Read more

Prescrire International <international@prescrire.org>

<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Independent Drug and Healthcare Newsletter for June 2018, Prescrire International <=